Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
Holding ENTA?
Track your performance easily

Enanta Pharmaceuticals (ENTA) Income Statement

158 Followers

Enanta Pharmaceuticals Income Statement

Last quarter (Q3 2024), Enanta Pharmaceuticals's total revenue was $17.97M, a decrease of -23.80% from the same quarter last year. In Q3, Enanta Pharmaceuticals's net income was $-22.66M. See Enanta Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
$ 72.66M$ 79.20M$ 86.16M$ 97.07M$ 122.47M$ 205.20M
Cost of Revenue
----$ -164.11M$ 168.46M
Gross Profit
$ 72.66M$ 79.20M$ 86.16M$ 97.07M$ 122.47M$ 205.20M
Operating Expense
$ 207.90M$ 216.41M$ 210.00M$ 206.65M$ 164.11M$ 168.46M
Operating Income
$ -135.24M$ -137.21M$ -123.84M$ -109.57M$ -41.64M$ 36.74M
Net Non Operating Interest Income Expense
$ 5.70M$ 6.21M$ 1.57M$ 2.02M$ 6.47M$ 8.82M
Other Income Expense
--$ 83.00K$ 27.00K$ -149.00K$ -9.34M
Pretax Income
$ -129.54M$ -131.00M$ -122.19M$ -107.58M$ -35.02M$ 45.56M
Tax Provision
$ 3.25M$ 2.82M$ -433.00K$ -28.58M$ 1.15M$ -826.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -132.79M$ -133.82M$ -121.75M$ -79.00M$ -36.17M$ 46.38M
Basic EPS
$ -6.30$ -6.38$ -5.91$ -3.92$ -1.81$ 2.37
Diluted EPS
$ -6.30$ -6.38$ -5.91$ -3.92$ -1.81$ 2.21
Basic Average Shares
$ 84.36M$ 20.97K$ 20.60K$ 20.17M$ 19.94M$ 19.58M
Diluted Average Shares
$ 84.36M$ 20.97K$ 20.60K$ 20.17M$ 19.94M$ 20.97M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 207.90M$ 216.41M$ 210.00M$ 206.65M-$ 336.92M
Net Income From Continuing And Discontinued Operation
$ -132.79M$ -133.82M$ -121.75M$ -79.00M$ -36.17M$ 46.38M
Normalized Income
$ -58.10M$ -103.49M----
Interest Expense
------
EBIT
$ -121.75M$ -125.85M$ -122.19M$ -107.58M$ -41.64M$ 45.56M
EBITDA
$ -118.27M$ -123.48M$ -119.22M$ -104.25M$ -37.99M$ 44.48M
Currency in USD

Enanta Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis